Publicacions dels grups de recerca: Febrer 2013
Tecnologies sanitàries i resultats en Atenció Primària 6/7; FI= 16,372
Alvarez-Galvez J, Rodero-Cosano ML, Motrico E, Salinas-Pérez JA, García-Alonso C, Salvador-Carulla L. The impact of socio-economic status on self-rated health: study of 29 countries using European social surveys (2002-2008).. Int J Environ Res Public Health 2013 ;10 (3) :747-61 Factor d'impacte: 1,605 Quartil: Q3
Cartwright M, Hirani SP, Rixon L, Beynon M, Doll H, Bower P, Bardsley M, Steventon A, Knapp M, Henderson C, Rogers A, Sanders C, Fitzpatrick R, Barlow J, Newman SP, Whole Systems Demonstrator evaluation team. Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial.. BMJ 2013 :in print
Montero-Marín J, Carrasco JM, Roca M, Serrano Blanco A, Gili M, Mayoral F, Luciano JV, López-Del-Hoyo Y, Olivan B, Collazo F, Araya R, Baños R, Botella C, García-Campayo J. Expectations, experiences, and attitudes of patients and primary care health professionals regarding online psychotherapeutic interventions for depression: protocol for a qualitative study.. BMC Psychiatry 2013 :in print Factor d'impacte: 2,552 Quartil: Q2
Mulhern B, Rowen D, Brazier J, Smith S, Romeo R, Tait R, Watchurst C, Chua KC, Loftus V, Young T, Lamping D, Knapp M, Howard R, Banerjee S. Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation.. Health Technol Assess 2013 ;17 (5) :1-140 Factor d'impacte: 4,255 Quartil: Q1
Serrano-Troncoso E, Guidi M, Alda-Díez JA. Is psychological treatment efficacious for attention deficit hyperactivity disorder (ADHD)? Review of nonpharmacological treatments in children and adolescents with ADHD.. Actas Esp Psiquiatr 2013 ;41 (1) :44-51 Factor d'impacte: 0,589 Quartil: Q4
Snell T, Knapp M, Healey A, Guglani S, Evans-Lacko S, Fernández JL, Meltzer H, Ford T. Economic impact of childhood psychiatric disorder on public sector services in Britain: estimates from national survey data.. J Child Psychol Psychiatry 2013 :in print Factor d'impacte: 4,281 Quartil: Q1
Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Beynon M, Hirani S, Cartwright M, Rixon L, Knapp M, Henderson C, Rogers A, Hendy J, Fitzpatrick R, Newman S. Effect of telecare on use of health and social care services: findings from the Whole Systems Demonstrator cluster randomised trial.. Age Ageing 2013 :in print Factor d'impacte: 3,090 Quartil: Q2
Recerca i innovació en Cirurgia 1/1; FI= 0,874
Parés D. How can we improve the number of scientific publications in general surgery?. Cir Esp 2013 :in print (Patologia funcional de l'aparell digestiu) Factor d'impacte: 0,874 Quartil: Q3
Pediatria 1/1; FI= 2,447
Serrano E, Ezpeleta L, Castro J. Comorbidity and phenomenology of bipolar disorder in children with ADHD.. J Atten Disord 2013 :in print Factor d'impacte: 2,447 Quartil: Q2
Medicina general 1/1; FI= 2,767
Malafarina V, Uriz-Otano F, Gil-Guerrero L, Iniesta R. The anorexia of ageing: Physiopathology, prevalence, associated comorbidity and mortality. A systematic review.. Maturitas 2013 :in print Factor d'impacte: 2,767 Quartil: Q2
Malalties infeccioses i immunopatologia infantil 4/6; FI= 10,343
Baquero-Artigao F, Del Castillo Martín F, Fuentes Corripio I, Goncé Mellgren A, Fortuny-Guasch C, De la Calle Fernández-Miranda M, González-Tomé MI, Couceiro Gianzo JA, Neth O, Ramos Amador JT, Grupo de Trabajo de Infección Congénita y Perinatal de la Sociedad Española de Infectología Pediátrica (SEIP) Guía de la Sociedad Española de Infectología Pediátrica para el diagnóstico y tratamiento de la toxoplasmosis congénita. An Pediatr (Barc) 2013 :in print (VIH) Factor d'impacte: 0,770 Quartil: Q4
Ciruela P, Soldevila N, Selva L, Hernández S, García-García JJ, Moraga F, de Sevilla MF, Codina G, Planes AM, Esteva C, Coll F, Cardeñosa N, Jordan I, Batalla J, Salleras L, Muñoz-Almagro C, Domínguez A. Are risk factors associated with invasive pneumococcal disease according to different serotypes?. Hum Vaccin Immunother. 2013 :in print (Vigilància epidemiològica molecular de les malalties prevenibles amb vacunes)
Dapena M, Figueras C, Noguera-Julian A, Fortuny C, De José MI, Mellado MJ, Gavilán C, Falcón-Neyra MD, Navarro ML, De Ory SJ, López C, Mayol L, Méndez M, Ciria LM, Coll MT, García L, Nuñez E, Espiau M, Soler-Palacín P. Implementation of Occult Hepatitis Screening in the Spanish Cohort of HIV-Infected Pediatric Patients.. Pediatr Infect Dis J 2013 :in print (VIH) Factor d'impacte: 3,577 Quartil: Q1
González-Tomé MI, Rivera M, Camaño I, Norman F, Flores-Chávez M, Rodriguez-Gomez L, Fumadó V, García-López Hortelano M, Lopez-Vélez R, González-Granado Ll, García-Burguillo A, Santos MD, Avila O. Recomendaciones para el diagnóstico, seguimiento y tratamiento de la embarazada y del niño con enfermedad de Chagas. Enferm Infecc Microbiol Clin 2013 :in print (Vigilància epidemiològica molecular de les malalties prevenibles amb vacunes) Factor d'impacte: 1,491 Quartil: Q3
Muñoz-Almagro C, Navarro-Torne A, Pallares R. Epidemiologic and Clinical Implications of Second-Generation Pneumococcal Conjugate Vaccines.. Curr Infect Dis Rep 2013 :in print (Vigilància epidemiològica molecular de les malalties prevenibles amb vacunes)
Pons R, Syrengelas D, Youroukos S, Orfanou I, Dinopoulos A, Cormand B, Ormazábal A, García-Cazorla A, Serrano M, Artuch R. Levodopa-Induced Dyskinesias in Tyrosine Hydroxylase Deficiency.. Mov Disord 2013 :in print (SNC) Factor d'impacte: 4,505 Quartil: Q1
Malalties de l'adult amb origen fetal o en els primers anys de vida 3/3; FI= 10,430
De Zegher F, Sebastiani G, Díaz M, Gómez-Roig MD, López-Bermejo A, Ibáñez L. Breast-feeding vs Formula-feeding for Infants Born Small-for-Gestational-Age: Divergent Effects on Fat Mass and on Circulating IGF-I and High-Molecular-Weight Adiponectin in Late Infancy.. J Clin Endocrinol Metab 2013 :in print (Retard del creixement intrauterí i alteracions) Factor d'impacte: 5,967 Quartil: Q1
Díaz M, Bassols J, Aragonés G, Mazarico E, López-Bermejo A, Ibáñez L. Decreased placental expression of pre-adipocyte factor-1 in children born small-for-gestational-age: Association to early postnatal weight gain.. Placenta 2013 :in print (Retard del creixement intrauterí i alteracions) Factor d'impacte: 3,693 Quartil: Q1
Moreno Hernando J, Thió Lluch M, Salguero García E, Rite Gracia S, Fernández Lorenzo JR, Echaniz-Urcelay I, Botet Mussons F, Herranz Carrillo G, Sánchez Luna M. Recomendaciones sobre transporte neonatal. An Pediatr (Barc) 2013 :in print (Estats fisiològics i patològics en el nadó) Factor d'impacte: 0,770 Quartil: Q4
Etiopatogènia i tractament dels trastorns mentals greus 1/1; FI= 2,240
Perales J, Cosco TD, Stephan BC, Haro JM, Brayne C. Health-related quality-of-life instruments for Alzheimer's disease and mixed dementia.. Int Psychogeriatr 2013 :in print (Epidemiologia) Factor d'impacte: 2,240 Quartil: Q2
Malalties neurològiques minoritàries de base genètica en l'àmbit pediàtric 3/6; FI= 21,343
Calpena E, Casado M, Martínez-Rubio D, Nascimento A, Colomer J, Gargallo E, García-Cazorla A, Palau F, Artuch R, Espinós C. 5-Oxoprolinuria in Heterozygous Patients for 5-Oxoprolinase (OPLAH) Missense Changes.. JIMD Reports 2013 ;7 :123-8 (Metabolisme energètic mitocondrial i atàxies)
Darling A, Poo P, Perez-Duenas B, Campistol J. Crisis oculógiras asociadas a fármacos: descripción de cuatro casos y revisión de la bibliografía. Rev Neurol 2013 :152-6 (PKU i altres aminoacidopaties)
Donaire A, Capdevila A, Carreño M, Setoain X, Rumià J, Aparicio J, Campistol J, Padilla N, Sanmartí F, Vernet O, Pintor L, Boget T, Ortells J, Bargalló N. Identifying the cortical substrates of interictal epileptiform activity in patients with extratemporal epilepsy: An EEG-fMRI sequential analysis and FDG-PET study.. Epilepsia 2013 :in print (Altres trastorns neurològics) Factor d'impacte: 3,961 Quartil: Q1
Handley MT, Morris-Rosendahl DJ, Brown S, Macdonald F, Hardy C, Bem D, Carpanini SM, Borck G, Martorell L, Izzi C, Faravelli F, Accorsi P, Pinelli L, Basel-Vanagaite L, Peretz G, Abdel-Salam GM, Zaki MS, Jansen A, Mowat D, Glass I, Stewart H, Mancini G, Lederer D, Roscioli T, Giuliano F, Plomp AS, Rolfs A, Graham JM, Seemanova E, Jackson IJ, Maher ER, Aligianis IA. Mutation Spectrum in RAB3GAP1, RAB3GAP2 and RAB18 and Genotype-Phenotype Correlations in Warburg Micro syndrome and Martsolf Syndrome.. Hum Mutat 2013 :in print (Altres trastorns neurològics) Factor d'impacte: 5,686 Quartil: Q1
Palanca D, Garcia-Cazorla A, Ortiz J, Jou C, Cusí V, Suñol M, Toll T, Pérez B, Ormazábal A, Fowler B, Artuch R. cblE-Type Homocystinuria Presenting with Features of Haemolytic-Uremic Syndrome in the Newborn Period.. JIMD Reports 2013 ;8 :57-62 (SNC)
Sarrión P, Sangorrin A, Urreizti R, Delgado A, Artuch R, Martorell L, Armstrong J, Anton J, Torner F, Vilaseca MA, Nevado J, Lapunzina P, Asteggiano CG, Balcells S, Grinberg D. Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas.. Sci Rep 2013 :in print Factor d'impacte: 11,696 Quartil: Q1
Càncer del desenvolupament 2/2; FI: 11,479
Cascón A, Inglada-Perez L, Comino-Méndez I, De Cubas AA, Letón R, Mora J, Marazuela M, Galofré JC, Quesada-Charneco M, Robledo M. Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.. Endocr Relat Cancer 2013 :in print (Neuroblastoma) Factor d'impacte: 4,364 Quartil: Q1
Ferronha T, Rabadán MA, Gil-Guiñón E, Le Dréau G, De Torres C, Martí E. LMO4 is an Essential Cofactor in the Snail2-Mediated Epithelial-to-Mesenchymal Transition of Neuroblastoma and Neural Crest Cells.. J Neurosci 2013 ;33 (7) :2773-83 (Biobanc i diagnòstic molecular) Factor d'impacte: 7,115 Quartil: Q1